Vetoquinol

Sales 3rd Quarter 2023 - Seite 2

Vetoquinol has been listed on Euronext Paris since 2006 (symbol: VETO).

The Vetoquinol share is eligible for the French PEA and PEA-PME personal equity plans.

ANNEX

€m	2023	2022	Change (reported data)	Change (constant exchange rates)
Q1 Sales	145.4	135.0	+7.7%	+7.2%
Q2 Sales	110.8	135.8	-18.3%	-16.3%
Q3 Sales	135.8	134.1	+1.3%	+5.1%
YTD Sep Sales	392.0	404.9	-3.2%	-1.4%

ALTERNATIVE PERFORMANCE INDICATORS

Vetoquinol Group management considers that these indicators, which are not defined by IFRS, provide additional information that is relevant for shareholders seeking to analyze underlying trends and Group performance and financial position. They are used by management for performance analysis.

Essentials products:The products referred to as “Essentials” comprise veterinary drugs and non-medical products sold by the Vetoquinol Group. They are existing or potential market-leading products designed to meet the daily requirements of vets in the companion animal or livestock sector. They are intended for sale worldwide and their scale effect improves their economic performance.

Constant exchange rates:Application of the previous period’s exchange rates to the current financial year, all other things remaining equal.

Like-for-like (LFL) growth: Year-on-year sales growth in terms of volume and/or price at constant consolidation scope and exchange rates.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231026741450/en/

The Vetoquinol Stock at the time of publication of the news with a raise of +1,96 % to 80,80EUR on Lang & Schwarz stock exchange (26. Oktober 2023, 17:56 Uhr).